Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Straumann Holding AG
  6. Summary
    STMN   CH0012280076

STRAUMANN HOLDING AG

(STMN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
05/03/2021 05/04/2021 05/05/2021 05/06/2021 05/07/2021 Date
1330.5(c) 1307.5(c) 1352.5(c) 1358.5(c) 1377(c) Last
26 807 27 413 28 692 35 666 22 486 Volume
+1.99% -1.73% +3.44% +0.44% +1.36% Change
More quotes
Financials
Sales 2021 1 793 M 1 990 M 1 990 M
Net income 2021 368 M 408 M 408 M
Net Debt 2021 8,73 M 9,69 M 9,69 M
P/E ratio 2021 58,4x
Yield 2021 0,50%
Sales 2022 2 014 M 2 235 M 2 235 M
Net income 2022 434 M 482 M 482 M
Net cash position 2022 197 M 219 M 219 M
P/E ratio 2022 49,2x
Yield 2022 0,59%
Capitalization 21 903 M 24 274 M 24 313 M
EV / Sales 2021 12,2x
EV / Sales 2022 10,8x
Nbr of Employees 7 193
Free-Float 64,8%
More Financials
Company
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to... 
More about the company
Notations Surperformance© of Straumann Holding AG
Trading Rating : Investor Rating :
More Ratings
All news about STRAUMANN HOLDING AG
05/05Kepler Cheuvreux Lifts Price Target on Straumann, Maintains Hold Recommendati..
MT
05/04STRAUMANN  : Bank Vontobel Lifts Price Target on Straumann Holding, Maintains Bu..
MT
04/29STRAUMANN  : Bumps Up FY21 Revenue Outlook After 32% Growth in Q1
MT
04/29STRAUMANN  : First-quarter 2021 report – Media Release
PU
04/29Straumann Group reports very strong first-quarter sales results accelerated b..
TE
04/23EQS-ADHOC  : Medartis Holding AG : Annual General Meeting approves all proposals..
DJ
04/16INVITATION : Straumann Group 2021 first-quarter financial results webcast
TE
04/13STRAUMANN  : Berenberg Lifts Price Target on Straumann, Maintains Hold Recommend..
MT
04/13STRAUMANN HOLDING AG : Ex-dividend day for final dividend
FA
04/09Straumann Group shareholders elect Petra Rumpf as a new Board member and appr..
TE
04/09STRAUMANN  : Stifel Lifts Price Target on Straumann, Maintains Hold Recommendati..
MT
03/26Global markets live: Microsoft, Burberry, Greensill….
03/26STRAUMANN  : expand s presence in China building its first manufacturing, educat..
PU
03/26Straumann Group expands presence in China building its first manufacturing, e..
TE
03/25PRESS RELEASE  : Announcement | MCH Group | Result and Annual Report 2020
DJ
More news
News in other languages on STRAUMANN HOLDING AG
05/07Bourse Zurich: vague verte dans les premiers échanges, avant l'emploi aux USA
05/05Aktien Schweiz Schluss: Erholung auf breiter Front nach Vortagesverlusten
05/03Bourse Zurich: dans le vert, le SMI termine au-dessus des 11'100 points
05/03AKTIEN ZÜRICH SCHLUSS : SMI startet fester in den Mai - Über 11 100 Punkte
05/03Bourse Zurich: bien ancrée dans le vert, la pharma en soutien
More news
Analyst Recommendations on STRAUMANN HOLDING AG
More recommendations
Chart STRAUMANN HOLDING AG
Duration : Period :
Straumann Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRAUMANN HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 1 206,13 CHF
Last Close Price 1 377,00 CHF
Spread / Highest target 14,5%
Spread / Average Target -12,4%
Spread / Lowest Target -42,8%
EPS Revisions
Managers and Directors
NameTitle
Guillaume Daniellot Chief Executive Officer
Peter Hackel Chief Financial Officer
Gilbert Achermann Chairman
Mark D. Johnson Head-Research, Development & Operations
H. C. Thomas Straumann Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
STRAUMANN HOLDING AG33.49%24 274
SONOVA HOLDING AG18.70%19 067
DEMANT A/S34.66%12 669
COCHLEAR LIMITED15.34%11 247
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.15.04%3 252
ÖSSUR HF.-5.06%3 172